Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis
Top Cited Papers
Open Access
- 1 January 2001
- journal article
- clinical trial
- Published by Elsevier BV in Gastroenterology
- Vol. 120 (1), 13-20
- https://doi.org/10.1053/gast.2001.20912
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Oral Delayed-Release MesalazineDrugs, 1999
- Oral contraceptive use and smoking are risk factors for relapse in Crohn's diseaseGastroenterology, 1998
- Clinical Course during the 1st Year after Diagnosis in Ulcerative Colitis and Crohn's Disease: Results of a Large, Prospective Population-based Study in Southeastern Norway, 1990-93Scandinavian Journal of Gastroenterology, 1997
- Course of ulcerative colitis: Analysis of changes in disease activity over yearsGastroenterology, 1994
- Olsalazine in maintenance of clinical remission in patients with ulcerative colitisDigestive Diseases and Sciences, 1993
- Why do patients with ulcerative colitis relapse?Gut, 1990
- Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase [see comments]Blood, 1989
- Ulcerative Colitis in Remission: Is It Possible to Predict the Risk of Relapse?Digestion, 1989
- Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitisGastroenterology, 1988
- CONTROLLED TRIAL OF SULPHASALAZINE IN MAINTENANCE THERAPY FOR ULCERATIVE COLITISThe Lancet, 1965